The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth

Roberto Pili, Joan Chang, Richard A. Partis, Richard A. Mueller, Francis J. Chrest, Antonino Passaniti

Research output: Contribution to journalArticle

170 Citations (Scopus)

Abstract

The development of drugs that target the tumor neovasculature may hold promise in inhibiting tumor growth. Experiments in vivo with castanospermine, an inhibitor of the glucosidases that convert protein N-linked high mannose carbohydrates to complex oligosaccharides, resulted in significant inhibition of tumor growth in nude mice. Angiogenesis to basic fibroblast growth factor in castanospermine-treated C57/BL mice was similarly reduced. Endothelial cell proliferation, invasion of basement membrane, and differentiation are crucial steps during neovascularization. In vitro differentiation models using Matrigel and postconfluent cultures of endothelial cells were used to study the effects of glycosidase inhibitors on endothelial cell behavior. FACS analysis of cell surface oligosaccharides using either Concanavalin A or L-phytohemagglutinin lectins confirmed an increase in high mannose groups and a decrease in tri- and tetra antennary β-linked galactose-N-acetylglucosamine on mannose residues of Asn-linked oligosaccharides upon drug treatment Castanospermine and the glucosidase inhibitor N-methyldeoxynojirimycin prevented the morphological differentiation of endothelial cells in vitro. These compounds did not alter the proliferation of cultured endothelial cells or their ability to attach to various extracellular matrix molecules. However, the cells showed a reduced ability to migrate and to invade basement membrane gels in vitro and an increased tendency to form aggregates that was inhibitable by D-mannose. These studies suggest that certain cell surface oligosaccharides are required for angiogenesis and that glucosidase inhibitors that alter these structures on endothelial cells are able to inhibit tumor growth.

Original languageEnglish (US)
Pages (from-to)2920-2926
Number of pages7
JournalCancer Research
Volume55
Issue number13
StatePublished - Jul 1 1995

Fingerprint

Glycosylation
Endothelial Cells
Mannose
Glucosidases
Oligosaccharides
Growth
Neoplasms
Aptitude
Basement Membrane
Angiogenesis Inhibitors
Acetylglucosamine
Glycoside Hydrolases
Phytohemagglutinins
Fibroblast Growth Factor 2
Concanavalin A
Galactose
Lectins
Nude Mice
Pharmaceutical Preparations
Extracellular Matrix

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pili, R., Chang, J., Partis, R. A., Mueller, R. A., Chrest, F. J., & Passaniti, A. (1995). The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth. Cancer Research, 55(13), 2920-2926.

The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth. / Pili, Roberto; Chang, Joan; Partis, Richard A.; Mueller, Richard A.; Chrest, Francis J.; Passaniti, Antonino.

In: Cancer Research, Vol. 55, No. 13, 01.07.1995, p. 2920-2926.

Research output: Contribution to journalArticle

Pili, R, Chang, J, Partis, RA, Mueller, RA, Chrest, FJ & Passaniti, A 1995, 'The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth', Cancer Research, vol. 55, no. 13, pp. 2920-2926.
Pili, Roberto ; Chang, Joan ; Partis, Richard A. ; Mueller, Richard A. ; Chrest, Francis J. ; Passaniti, Antonino. / The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth. In: Cancer Research. 1995 ; Vol. 55, No. 13. pp. 2920-2926.
@article{9f43db5938ad4a66b4631245aba197da,
title = "The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth",
abstract = "The development of drugs that target the tumor neovasculature may hold promise in inhibiting tumor growth. Experiments in vivo with castanospermine, an inhibitor of the glucosidases that convert protein N-linked high mannose carbohydrates to complex oligosaccharides, resulted in significant inhibition of tumor growth in nude mice. Angiogenesis to basic fibroblast growth factor in castanospermine-treated C57/BL mice was similarly reduced. Endothelial cell proliferation, invasion of basement membrane, and differentiation are crucial steps during neovascularization. In vitro differentiation models using Matrigel and postconfluent cultures of endothelial cells were used to study the effects of glycosidase inhibitors on endothelial cell behavior. FACS analysis of cell surface oligosaccharides using either Concanavalin A or L-phytohemagglutinin lectins confirmed an increase in high mannose groups and a decrease in tri- and tetra antennary β-linked galactose-N-acetylglucosamine on mannose residues of Asn-linked oligosaccharides upon drug treatment Castanospermine and the glucosidase inhibitor N-methyldeoxynojirimycin prevented the morphological differentiation of endothelial cells in vitro. These compounds did not alter the proliferation of cultured endothelial cells or their ability to attach to various extracellular matrix molecules. However, the cells showed a reduced ability to migrate and to invade basement membrane gels in vitro and an increased tendency to form aggregates that was inhibitable by D-mannose. These studies suggest that certain cell surface oligosaccharides are required for angiogenesis and that glucosidase inhibitors that alter these structures on endothelial cells are able to inhibit tumor growth.",
author = "Roberto Pili and Joan Chang and Partis, {Richard A.} and Mueller, {Richard A.} and Chrest, {Francis J.} and Antonino Passaniti",
year = "1995",
month = "7",
day = "1",
language = "English (US)",
volume = "55",
pages = "2920--2926",
journal = "Cancer Research",
issn = "0008-5472",
number = "13",

}

TY - JOUR

T1 - The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth

AU - Pili, Roberto

AU - Chang, Joan

AU - Partis, Richard A.

AU - Mueller, Richard A.

AU - Chrest, Francis J.

AU - Passaniti, Antonino

PY - 1995/7/1

Y1 - 1995/7/1

N2 - The development of drugs that target the tumor neovasculature may hold promise in inhibiting tumor growth. Experiments in vivo with castanospermine, an inhibitor of the glucosidases that convert protein N-linked high mannose carbohydrates to complex oligosaccharides, resulted in significant inhibition of tumor growth in nude mice. Angiogenesis to basic fibroblast growth factor in castanospermine-treated C57/BL mice was similarly reduced. Endothelial cell proliferation, invasion of basement membrane, and differentiation are crucial steps during neovascularization. In vitro differentiation models using Matrigel and postconfluent cultures of endothelial cells were used to study the effects of glycosidase inhibitors on endothelial cell behavior. FACS analysis of cell surface oligosaccharides using either Concanavalin A or L-phytohemagglutinin lectins confirmed an increase in high mannose groups and a decrease in tri- and tetra antennary β-linked galactose-N-acetylglucosamine on mannose residues of Asn-linked oligosaccharides upon drug treatment Castanospermine and the glucosidase inhibitor N-methyldeoxynojirimycin prevented the morphological differentiation of endothelial cells in vitro. These compounds did not alter the proliferation of cultured endothelial cells or their ability to attach to various extracellular matrix molecules. However, the cells showed a reduced ability to migrate and to invade basement membrane gels in vitro and an increased tendency to form aggregates that was inhibitable by D-mannose. These studies suggest that certain cell surface oligosaccharides are required for angiogenesis and that glucosidase inhibitors that alter these structures on endothelial cells are able to inhibit tumor growth.

AB - The development of drugs that target the tumor neovasculature may hold promise in inhibiting tumor growth. Experiments in vivo with castanospermine, an inhibitor of the glucosidases that convert protein N-linked high mannose carbohydrates to complex oligosaccharides, resulted in significant inhibition of tumor growth in nude mice. Angiogenesis to basic fibroblast growth factor in castanospermine-treated C57/BL mice was similarly reduced. Endothelial cell proliferation, invasion of basement membrane, and differentiation are crucial steps during neovascularization. In vitro differentiation models using Matrigel and postconfluent cultures of endothelial cells were used to study the effects of glycosidase inhibitors on endothelial cell behavior. FACS analysis of cell surface oligosaccharides using either Concanavalin A or L-phytohemagglutinin lectins confirmed an increase in high mannose groups and a decrease in tri- and tetra antennary β-linked galactose-N-acetylglucosamine on mannose residues of Asn-linked oligosaccharides upon drug treatment Castanospermine and the glucosidase inhibitor N-methyldeoxynojirimycin prevented the morphological differentiation of endothelial cells in vitro. These compounds did not alter the proliferation of cultured endothelial cells or their ability to attach to various extracellular matrix molecules. However, the cells showed a reduced ability to migrate and to invade basement membrane gels in vitro and an increased tendency to form aggregates that was inhibitable by D-mannose. These studies suggest that certain cell surface oligosaccharides are required for angiogenesis and that glucosidase inhibitors that alter these structures on endothelial cells are able to inhibit tumor growth.

UR - http://www.scopus.com/inward/record.url?scp=0028981092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028981092&partnerID=8YFLogxK

M3 - Article

C2 - 7540952

AN - SCOPUS:0028981092

VL - 55

SP - 2920

EP - 2926

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 13

ER -